EBM Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cefalu, W. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cefalu, W. T.
Experimental Biology and Medicine 226:13-26 (2001)
© 2001 Society for Experimental Biology and Medicine


MINIREVIEW

Insulin Resistance: Cellular and Clinical Concepts

William T. Cefalu,1

Endocrine Unit, Department of Medicine, University of Vermont College of Medicine, Burlington, Vermont 05405

Insulin resistance is defined as a clinical state in which a normal or elevated insulin level produces an attenuated biologic response. Specifically, the biologic response most studied is insulin-stimulated glucose disposal, yet the precise cellular mechanism responsible is not yet known. However, the presence of insulin resistance is observed many years before the onset of clinical hyperglycemia and the diagnosis of Type 2 diabetes. Insulin resistance at this stage appears to be significantly associated with a clustering of cardiovascular risk factors predisposing the individual to accelerated cardiovascular disease. An overview of insulin resistance and the associated clinical insulin resistant state will be discussed.

Key Words: insulin • type 2 diabetes • atherosclerosis • insulin resistance • metabolic syndrome




This article has been cited by other articles:


Home page
Endocr. Rev.Home page
J. Nigro, N. Osman, A. M. Dart, and P. J. Little
Insulin Resistance and Atherosclerosis
Endocr. Rev., May 1, 2006; 27(3): 242 - 259.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
G. E. Umpierrez, D. Smiley, and A. E. Kitabchi
Narrative review: ketosis-prone type 2 diabetes mellitus.
Ann Intern Med, March 7, 2006; 144(5): 350 - 357.
[Abstract] [Full Text] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
E. Arikan and S. Sen
Endothelial Damage and Hemostatic Markers in Patients with Uncomplicated Mild-to-Moderate Hypertension and Relationship with Risk Factors
Clinical and Applied Thrombosis/Hemostasis, April 1, 2005; 11(2): 147 - 159.
[Abstract] [PDF]


Home page
Am J EpidemiolHome page
D. A. Lawlor, S. Ebrahim, M. May, and G. Davey Smith
(Mis)use of Factor Analysis in the Study of Insulin Resistance Syndrome
Am. J. Epidemiol., June 1, 2004; 159(11): 1013 - 1018.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. B. Wheatcroft, M. T. Kearney, A. M. Shah, D. J. Grieve, I. L. Williams, J. P. Miell, and P. A. Crossey
Vascular Endothelial Function and Blood Pressure Homeostasis in Mice Overexpressing IGF Binding Protein-1
Diabetes, August 1, 2003; 52(8): 2075 - 2082.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. Rehman, R. V. Considine, J. E. Bovenkerk, J. Li, C. A. Slavens, R. M. Jones, and K. L. March
Obesity is associated with increased levels of circulating hepatocyte growth factor
J. Am. Coll. Cardiol., April 16, 2003; 41(8): 1408 - 1413.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
W. J. Banz, M. A. Maher, W. G. Thompson, D. R. Bassett, W. Moore, M. Ashraf, D. J. Keefer, and M. B. Zemel
Effects of Resistance versus Aerobic Training on Coronary Artery Disease Risk Factors
Experimental Biology and Medicine, April 1, 2003; 228(4): 434 - 440.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
D. L. Krebs and D. J. Hilton
A New Role for SOCS in Insulin Action
Sci. Signal., February 11, 2003; 2003(169): pe6 - pe6.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
M.J. Iqbal, S. Yaegashi, R. Ahsan, D.A. Lightfoot, and W.J. Banz
Differentially abundant mRNAs in rat liver in response to diets containing soy protein isolate
Physiol Genomics, December 3, 2002; 11(3): 219 - 226.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
D. L. Krebs, R. T. Uren, D. Metcalf, S. Rakar, J.-G. Zhang, R. Starr, D. P. De Souza, K. Hanzinikolas, J. Eyles, L. M. Connolly, et al.
SOCS-6 Binds to Insulin Receptor Substrate 4, and Mice Lacking the SOCS-6 Gene Exhibit Mild Growth Retardation
Mol. Cell. Biol., July 1, 2002; 22(13): 4567 - 4578.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
W. T. Cefalu, Z. Q. Wang, X. H. Zhang, L. C. Baldor, and J. C. Russell
Oral Chromium Picolinate Improves Carbohydrate and Lipid Metabolism and Enhances Skeletal Muscle Glut-4 Translocation in Obese, Hyperinsulinemic (JCR-LA Corpulent) Rats
J. Nutr., June 1, 2002; 132(6): 1107 - 1114.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. H. Eckel, M. Wassef, A. Chait, B. Sobel, E. Barrett, G. King, M. Lopes-Virella, J. Reusch, N. Ruderman, G. Steiner, et al.
Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group II: Pathogenesis of Atherosclerosis in Diabetes
Circulation, May 7, 2002; 105 (18): e138 - e143.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the Society for Experimental Biology and Medicine.